NSE: ADVENZYMES · BSE: 540025 · ISIN INE837H01020
Advanced Enzyme Technologies Limited stock analysis
Advanced Enzyme Technologies Limited ranks #1614 in the TickerSutra evidence-ranked universe with a score of 52/100 and 95% data confidence. The latest captured fundamentals show ROCE of 14.0%, quarterly sales growth of 2.1% and quarterly profit growth of -7.1%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.02×
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- No calculated threshold risk in the current snapshot.
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹529cr | ₹203cr | ₹124cr | 38.0% |
| 2023 | ₹541cr | ₹158cr | ₹104cr | 29.0% |
| 2024 | ₹624cr | ₹206cr | ₹137cr | 33.0% |
| 2025 | ₹637cr | ₹196cr | ₹134cr | 31.0% |
| 2026 | ₹746cr | ₹230cr | ₹174cr | 31.0% |
| TTM | ₹750cr | ₹224cr | ₹172cr | 30.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 28, 2026
RoutineAdvanced Enzyme Technologies Ltd - 540025 - Closure of Trading WindowBSE · 28 Sept 2026Please find enclosed herewith the intimation regarding the closure of the Trading Window with effect from October 01, 2026.
RoutineAdvanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity sharesBSE · 25 Sept 2026Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 25, 2026
RoutineAdvanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity sharesBSE · 23 Sept 2026Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 23, 2026
RoutineAdvanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity sharesBSE · 22 Sept 2026Daily Report pursuant to Regulation 18(1) of the Buyback Regulations regarding the Equity Shares bought back on September 22, 2026
MANAGEMENT COMMENTARY
Signals from filed documents
I'm saying what was the challenges in the India market in this particular quarter? I would say that the first quarter was dull this time because of some price increases and other things. It takes some time to regroup and get back to the growth.
Our fundamentals remain strong, execution continues to be solid, and we are well positioned to capitalize on growth opportunities. We remain confident in delivering sustainable revenue growth consistent with our annual guidance. Page 3 of 19 EBITDA for the quarter came in at INR 510 million, down 10% YoY and 19% QoQ.
These statements involve inherent risks and uncertainties and are based on current expectations, forecasts, and assumptions. Actual results may differ materially from those expressed or implied in these statements, influenced by a range of factors including but not limited to economic conditions, changes in government poli cies, regulatory developments, and other unforeseen circumstances. Recipients are cautioned not
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…